After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. "We'll ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

A top-of-mind question for many clinical trial workers is whether AI could lead to job loss. After all, Goldman Sachs recently estimated that 300 million jobs could be lost or degraded due to AI ...

Google’s AI scours medical records, research papers, imaging, and clinical guidelines to help doctors diagnose diseases and evaluate treatment options. The tech giant’s already selling these ...

Google's DeepMind eyes clinical trials for AI-designed drugs in 2025 - report. Jan. 21, 2025 9:39 AM ET Alphabet Inc. (GOOG) Stock, GOOGL Stock By: Ravikash Bakolia, SA News Editor 2 Comments.